A
Andre Konski
Researcher at University of Pennsylvania
Publications - 243
Citations - 11455
Andre Konski is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 47, co-authored 239 publications receiving 10309 citations. Previous affiliations of Andre Konski include Toledo Hospital & Leonard Davis Institute of Health Economics.
Papers
More filters
Journal ArticleDOI
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
Vinai Gondi,Stephanie L. Pugh,Wolfgang A. Tomé,Chip Caine,Ben W Corn,Andrew A. Kanner,Howard A. Rowley,Vijayananda Kundapur,Albert S. DeNittis,Jeffrey Greenspoon,Andre Konski,Glenn Bauman,Sunjay Shah,Wenyin Shi,Merideth M Wendland,Lisa A. Kachnic,Minesh P. Mehta +16 more
TL;DR: Conformal avoidance of the hippocampus during WBRT is associated with preservation of memory and QOL as compared with historical series.
Journal ArticleDOI
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.
Stephen Lutz,Lawrence Berk,Eric L. Chang,Edward Chow,Carol A. Hahn,Peter Hoskin,David R. Howell,Andre Konski,Lisa A. Kachnic,Simon S. Lo,Arjun Sahgal,Larry N. Silverman,Charles von Gunten,Ehud Mendel,Andrew D. Vassil,Deborah Watkins Bruner,William F. Hartsell +16 more
TL;DR: Radiotherapy is a successful and time efficient method by which to palliate pain and/or prevent the morbidity of bone metastases and is recommended for surgical decompression and postoperative radiotherapy in highly selected patients with sufficient performance status and life expectancy.
Journal ArticleDOI
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
William F. Harstell,Charles Scott,Deborah Watkins Bruner,Charles W. Scarantino,Robert Ivker,Mack Roach,John H. Suh,W. Demas,Benjamin Movsas,Ivy A. Petersen,Andre Konski,Charles S. Cleeland,Nora A. Janjan,Michelle DeSilvio +13 more
TL;DR: Both regimens of palliative radiation therapy were equivalent in terms of pain and narcotic relief at 3 months and were well tolerated with few adverse effects.
Journal ArticleDOI
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
William F. Regine,Kathryn Winter,Ross A. Abrams,Howard Safran,John P. Hoffman,Andre Konski,Al B. Benson,John S. Macdonald,Mahesh Kudrimoti,Mitchel Fromm,Michael G. Haddock,Paul L. Schaefer,Christopher G. Willett,Tyvin A. Rich +13 more
TL;DR: The addition of gemcitabine to adjuvant fluorouracil-based chemoradiation was associated with a survival benefit for patients with resected pancreatic cancer, although this improvement was not statistically significant.
Journal ArticleDOI
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
K. Kian Ang,Qiang Zhang,David I. Rosenthal,Phuc Felix Nguyen-Tan,Eric J. Sherman,Randal S. Weber,James M. Galvin,James A. Bonner,Jonathan Harris,Adel K. El-Naggar,Maura L. Gillison,Richard C.K. Jordan,Andre Konski,Wade L. Thorstad,Andy Trotti,Jonathan J. Beitler,Adam S. Garden,William J. Spanos,Sue S. Yom,Rita Axelrod +19 more
TL;DR: Adding cetuximab to radiation-cisplatin did not improve outcome and hence should not be prescribed routinely, and the PFS and OS were higher in patients with p16-positive OPC, but outcomes did not differ by EGFR expression.